109 related articles for article (PubMed ID: 22035041)
1. Thalidomide in the treatment of psoriasis vulgaris: a pilot study.
Li L; Su F; Jin H
J Dermatol; 2011 Dec; 38(12):1180-2. PubMed ID: 22035041
[No Abstract] [Full Text] [Related]
2. Treatment of cutaneous sarcoidosis with thalidomide.
Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide in the treatment of refractory rheumatoid arthritis.
Keesal N; Wasserman MJ; Bookman A; Lapp V; Weber DA; Keystone EC
J Rheumatol; 1999 Nov; 26(11):2344-7. PubMed ID: 10555888
[TBL] [Abstract][Full Text] [Related]
4. A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma.
Lutzky J; Weber R; Nunez Y; Gillett M; Spitler L
J Immunother; 2009 Jan; 32(1):79-85. PubMed ID: 19307996
[TBL] [Abstract][Full Text] [Related]
5. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
Cunha PR; de Oliveira JR; Salles MJ; Jamora J; Bystryn JC
Int J Dermatol; 2004 Sep; 43(9):682-4. PubMed ID: 15357753
[No Abstract] [Full Text] [Related]
7. Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?
Katodritou E; Gastari V; Verrou E; Hadjiaggelidou C; Varthaliti M; Georgiadou S; Laschos K; Xirou P; Yiannaki E; Constantinou N; Markala D; Zervas K
Leuk Res; 2009 Aug; 33(8):1137-40. PubMed ID: 19250676
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.
Noel N; Mahlaoui N; Blanche S; Suarez F; Coignard-Biehler H; Durieu I; Godeberge P; Sokol H; Catherinot E; Poiree S; Chapdelaine H; Dunogue B; Bodemer C; Lecuit M; Fischer A; Lortholary O; Hermine O
J Allergy Clin Immunol; 2013 Oct; 132(4):997-1000.e1-4. PubMed ID: 23791514
[No Abstract] [Full Text] [Related]
9. [Thalidomide and thrombosis].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2003 Apr; 130(4):489. PubMed ID: 12843869
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris.
Hashizume H; Ito T; Yagi H; Takigawa M; Kageyama H; Furukawa F; Hata M; Shirahama S; Tanaka M; Higashishiba T; Machida H; Tsushima T; Matsushita K
J Dermatol; 2007 Jul; 34(7):430-4. PubMed ID: 17584318
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on changes of macrophage colony stimulating factor and transforming growth factor beta1 in male patients with ankylosing spondylitis taking thalidomide.
Yang PT; Xiao WG; Qin L; Zhao LJ; He LM; Ito M
Ann Rheum Dis; 2010 Apr; 69(4):781-2. PubMed ID: 19717400
[No Abstract] [Full Text] [Related]
12. Discontinuation of methotrexate in psoriasis.
Due E; Blomberg M; Skov L; Zachariae C
Acta Derm Venereol; 2012 Jul; 92(4):353-4. PubMed ID: 22001863
[No Abstract] [Full Text] [Related]
13. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM
Arthritis Rheum; 1999 Oct; 42(10):2259-60. PubMed ID: 10524707
[No Abstract] [Full Text] [Related]
14. Cutaneous sarcoidosis successfully treated with low doses of thalidomide.
Rousseau L; Beylot-Barry M; Doutre MS; Beylot C
Arch Dermatol; 1998 Aug; 134(8):1045-6. PubMed ID: 9722748
[No Abstract] [Full Text] [Related]
15. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.
Kamalaporn P; Saravanan R; Cirocco M; May G; Kortan P; Kandel G; Marcon N
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1347-50. PubMed ID: 19730385
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide in multiple myeloma: state of art.
Tosi P; Cavo M
Haematologica; 2002 Mar; 87(3):233-4. PubMed ID: 11869932
[No Abstract] [Full Text] [Related]
17. [New therapeutic application of thalidomide].
Saano V
Duodecim; 1996; 112(7):623-7. PubMed ID: 10592629
[No Abstract] [Full Text] [Related]
18. Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study.
Feyler S; Rawstron A; Jackson G; Snowden JA; Cocks K; Johnson RJ
Br J Haematol; 2007 Nov; 139(3):429-33. PubMed ID: 17910633
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study.
Xiao Z; Xu Z; Zhang Y; Qin T; Zhang H; Fang L
Leuk Res; 2011 Jan; 35(1):61-5. PubMed ID: 20591481
[TBL] [Abstract][Full Text] [Related]
20. [Discoid lupus, recurrent aphthosis. New indications for thalidomide?].
MMW Fortschr Med; 2001 Feb; 143(8):33. PubMed ID: 11265535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
